IVERIC BIO/ US46583P1021 /
| 2023-07-10 10:01:14 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 39.95USD | - | 199,958 Turnover: 7.98 mill. |
-Bid Size: - | -Ask Size: - | 4.07 bill.USD | 0.00% | - |
Fundamentals
| FY 2021 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -1.12 USD | -1.75% |
| EPS Diluted: | -1.12 USD | -1.75% |
| Revenues per Share: | - USD | - |
| Book Value per Share: | 3.54 USD | 37.02% |
| Cash Flow per Share: | -0.97 USD | 8.63% |
| Dividend per Share: | 0.00 USD | - |
| Total | in mill. | |
| Revenues: | - USD | - |
| Net Income: | -114.50 USD | 35.50% |
| Operating Cash Flow: | -98.60 USD | - |
| Cash and Cash Equivalents: | 261.40 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | - | - |
| P/BV ratio: | 11.29 | 4.72 |
| P/CF Ratio: | -41.27 | -17.27 |
| PEG: | 20.33 | - |
| Earnings Yield: | -2.80% | -6.70% |
| Dividend Yield: | 0.00% | 0.00% |
| Market Capitalization | ||
| Market Capitalization: | 4.07 bill. USD | 1.7 bill. USD |
| Free Float Market Cap.: | 3.12 bill. USD | 1.31 bill. USD |
| Market Cap. / Employee: | 109.99 mill. USD | 46.03 mill. USD |
| Shares Outstanding: | 101.87 mill. | |
Profitability
| Gross Profit Margin: | - |
| EBIT Margin: | - |
| Net Profit Margin: | - |
| Return on Equity: | -31.76% |
| Return on Assets: | -29.40% |
Financial Strength
| Liquidity I / Cash Ratio: | 926.95% |
| Liquidity II / Quick Ratio: | 926.95% |
| Liquidity III / Current Ratio: | 1,374.11% |
| Debt / Equity Ratio: | 8.02% |
| Dynam. Debt / Equity Ratio: | -29.31% |
Efficiency
| Employees: | 37 |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | -3,094,594.59 USD |
| Total Assets / Employee: | 10,524,324.32 USD |
| * Fiscal Year End: | 2021-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
